μ3 Opiate receptor expression in lung and lung carcinoma: ligand binding and coupling to nitric oxide release
- 1 November 1999
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 146 (1), 45-51
- https://doi.org/10.1016/s0304-3835(99)00227-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The multifaceted roles of nitric oxide in cancerCarcinogenesis: Integrative Cancer Research, 1998
- Promoter Region and Alternatively Spliced Exons of the Rat μ‐Opioid Receptor GeneJournal of Neurochemistry, 1996
- Opioid and Opiate Immunoregulatory ProcessesCritical Reviews in Immunology, 1996
- Nitric Oxide Synthase Pathway May Mediate Human Natural Killer Cell CytotoxicityScandinavian Journal of Immunology, 1995
- Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptorFEBS Letters, 1995
- Nitric Oxide Induces Oxidative Damage in Addition to Deamination in Macrophage DNAChemical Research in Toxicology, 1995
- Expression of two variants of the human μ opioid receptor mRNA in SK‐N‐SH cells and human brainFEBS Letters, 1994
- Characterisation of μ-opioid receptors on SH-SY5Y cells using naloxonazine and β-funaltrexamineEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblastsCarcinogenesis: Integrative Cancer Research, 1993
- Antitumor activity of naltrexone and correlation with steroid hormone receptorsBiochemical and Biophysical Research Communications, 1991